Towa Pharmaceutical
TSE:4553
¥ 4.200,00
+ ¥50,00 (1,20%)
4.200,00 ¥
+¥50,00 (1,20%)
End-of-day quote: 03/06/2026

Quick Analysis

¥0,00
Earnings Per Share
¥5,27k
Revenue Per Share
36,49%
Gross Margin %
¥204,30 B
Market Cap
¥195,08 B
Long-Term Debt
Earnings Per Share
¥0,00
Revenue Per Share
¥5,27k
Gross Margin %
36,49%
Market Cap
¥204,30 B
Long-Term Debt
¥195,08 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
EPS Earnings Per Share ¥385,71 ¥328,59 ¥44,72 ¥323,36 ¥283,62 ¥294,74 ¥273,85 ¥132,00 ¥113,32 ¥154,19 ¥218,07 ¥117,54 ¥121,62 ¥111,49 ¥113,53 ¥89,36 ¥73,34 ¥52,28 ¥50,44 ¥18,49
Earnings Earnings ¥18,99B ¥16,17B ¥2,20B ¥15,92B ¥13,96B ¥14,50B ¥13,48B ¥6,50B ¥5,58B ¥7,59B ¥11,12B ¥5,99B ¥6,20B ¥5,68B ¥5,85B ¥4,60B ¥3,78B ¥2,69B ¥2,60B ¥952,24M
RPS Revenue Per Share ¥5,27k ¥4,63k ¥4,24k ¥3,36k ¥3,15k ¥2,24k ¥2,14k ¥1,90k ¥1,73k ¥1,67k ¥1,40k ¥1,20k ¥1,08k ¥955,46 ¥896,02 ¥758,13 ¥698,38 ¥611,56 ¥567,67 ¥469,78
Revenue Revenue ¥259,59B ¥227,93B ¥208,86B ¥165,62B ¥154,90B ¥110,38B ¥105,10B ¥93,43B ¥84,95B ¥82,12B ¥71,47B ¥61,35B ¥55,24B ¥48,72B ¥46,15B ¥39,04B ¥35,97B ¥31,50B ¥29,24B ¥24,19B
OCF Operating Cash Flow ¥23,40B ¥8,21B ¥2,54B ¥22,13B ¥12,01B ¥19,16B ¥19,00B ¥19,23B ¥10,20B ¥3,73B ¥8,04B ¥8,14B ¥8,65B ¥3,38B ¥5,74B ¥6,56B ¥0,00M ¥3,71B ¥2,65B ¥0,00M
FCF Free Cash Flow ¥-9,99B ¥-32,18B ¥-26,19B ¥10,99B ¥2,87B ¥14,62B ¥7,86B ¥4,75B ¥-10,29B ¥-9,82B ¥-5,28B ¥190,00M ¥-1,88B ¥-5,63B ¥-2,86B ¥4,22B ¥0,00M ¥1,72B ¥1,48B ¥0,00M
OM Operating Margin 8,95% 7,74% 2,64% 11,19% 12,87% 14,65% 15,49% 12,46% 8,41% 13,56% 15,55% 12,70% 14,09% 18,98% 21,22% 19,72% 18,03% 16,93% 15,15% 9,20%
GM % Gross Margin % 36,49% 35,70% 34,81% 42,38% 42,25% 45,88% 46,05% 46,08% 45,97% 50,97% 51,75% 49,27% 50,22% 54,87% 53,74% 51,86% 48,99% 47,55% 46,68% 45,29%
FCFS Free Cash Flow Per Share ¥-153,30 ¥-623,60 ¥-567,02 ¥175,47 ¥48,16 ¥294,54 ¥155,42 ¥78,38 ¥-222,99 ¥-208,38 ¥-111,19 ¥-1,45 ¥-39,87 ¥-116,59 ¥-61,34 ¥78,74 ¥31,60 ¥32,86 ¥28,61 ¥-25,05
LT Debt Long-Term Debt ¥195,08B N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 49,23M 49,22M 49,22M 49,22M 49,21M 49,21M 49,21M 49,21M 49,21M 49,21M 50,99M 50,99M 50,99M 50,99M 51,5M 51,5M 51,5M 51,5M 51,5M 51,5M
×